TY - JOUR
T1 - Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system
AU - Haskó, György
AU - Szabó, Csaba
PY - 1998/11/1
Y1 - 1998/11/1
N2 - The sympathetic nervous system innervates immune organs and, when activated, releases its signaling molecules in the vicinity of immune cells. The released molecules include the 'classical' transmitters norepinephrine and epinephrine and the co-transmitters ATP and adenosine. Immune cells express various adrenergic and purinergic receptors that are sensitive to these molecules, and the production of immune/inflammatory mediators (cytokines, chemokines, and free radicals) is modulated by activation of these receptors. Notably, the production of tumor necrosis factor-α, interleukin-6, -10, and -12, and the chemokine macrophage inflammatory protein 1α and the production of the free radical nitric oxide, produced by the inducible nitric oxide synthase, have been shown to be altered by activation of these receptors. Alterations in the production of the immune mediators may contribute to the development of various diseases. On the other hand, novel experimental therapies based on the modulation of adrenergic or purinergic receptors on immune cells are emerging. Such approaches may have beneficial effects in limiting tissue injury and suppressing symptoms in certain pathophysiological states. Copyright (C) 1998 Elsevier Science Inc.
AB - The sympathetic nervous system innervates immune organs and, when activated, releases its signaling molecules in the vicinity of immune cells. The released molecules include the 'classical' transmitters norepinephrine and epinephrine and the co-transmitters ATP and adenosine. Immune cells express various adrenergic and purinergic receptors that are sensitive to these molecules, and the production of immune/inflammatory mediators (cytokines, chemokines, and free radicals) is modulated by activation of these receptors. Notably, the production of tumor necrosis factor-α, interleukin-6, -10, and -12, and the chemokine macrophage inflammatory protein 1α and the production of the free radical nitric oxide, produced by the inducible nitric oxide synthase, have been shown to be altered by activation of these receptors. Alterations in the production of the immune mediators may contribute to the development of various diseases. On the other hand, novel experimental therapies based on the modulation of adrenergic or purinergic receptors on immune cells are emerging. Such approaches may have beneficial effects in limiting tissue injury and suppressing symptoms in certain pathophysiological states. Copyright (C) 1998 Elsevier Science Inc.
KW - ATP
KW - Epinephrine
KW - Interleukin
KW - Neurotransmission
KW - Norepinephrine
KW - Purinergic
KW - Sympathetic nervous system
KW - Tumor necrosis factor
UR - http://www.scopus.com/inward/record.url?scp=0031741566&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031741566&partnerID=8YFLogxK
U2 - 10.1016/S0006-2952(98)00153-1
DO - 10.1016/S0006-2952(98)00153-1
M3 - Comment/debate
C2 - 9802316
AN - SCOPUS:0031741566
SN - 0006-2952
VL - 56
SP - 1079
EP - 1087
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 9
ER -